EP2223922 - Inhibitors of human phosphatidyl-inositol 3-kinase delta [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.01.2017 Database last updated on 24.08.2024 | Most recent event Tooltip | 06.01.2017 | No opposition filed within time limit | published on 08.02.2017 [2017/06] | Applicant(s) | For all designated states ICOS Corporation Lilly Corporate Center Indianapolis IN 46285 / US | [2015/37] |
Former [2010/35] | For all designated states ICOS Corporation 22021 20th Avenue S.E. Bothell WA 98201 / US | Inventor(s) | 01 /
Sadhu, Chancal 903 223rd Street SE Bothell, WA 98012 / US | 02 /
Dick, Ken 22517 1st Place West Bothell, VA 98021-8321 / US | 03 /
Treiberg, Jennifer 19411 Grannis road Bothell, WA 98012 / US | 04 /
Sowell, Gregory 9423 61st Avenue W. Makilteo, WA 98275 / US | 05 /
Kesicki, Edward A. 2504 208th Place SE Bothell, WA 98021 / US | 06 /
Oliver, Amy 3312 189th Place SE Bothell, WA 98012 / US | [2016/09] |
Former [2010/35] | 01 /
Sadhu, Chancal 903 223rd Street SE Bothell, WA 98012 / US | ||
02 /
Dick, Ken 22517 1st Place West Bothell, VA 98021-8321 / US | |||
03 /
Treiberg, Jennifer 19411 Grannis road Bothell, WA 98012 / US | |||
04 /
Sowell, Gregory 9423 61st Avenue W. Makilteo, WA 98275 / US | |||
05 /
Kesicki, Edward A. 2504 208th Place SE Bothell, WA 98021 / US | |||
06 /
Oliver, Amy 3312 189th Place SE Bothell, WA 98012 / US | Representative(s) | Goodfellow, Hugh Robin, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2014/27] |
Former [2013/22] | Bailey, Sam Rogerson Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | ||
Former [2012/13] | Barton, Matthew Thomas, et al Forrester & Boehmert SkyGarden Erika-Mann-Strasse 11 80636 München / DE | ||
Former [2010/35] | Barton, Matthew Thomas Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE | Application number, filing date | 10163434.3 | 24.04.2001 | [2010/35] | Priority number, date | US20000199655P | 25.04.2000 Original published format: US 199655 P | US20000238057P | 05.10.2000 Original published format: US 238057 P | [2010/35] | Previously filed application, date | EP20080006457 | 24.04.2001 | [2010/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2223922 | Date: | 01.09.2010 | Language: | EN | [2010/35] | Type: | A3 Search report | No.: | EP2223922 | Date: | 27.04.2011 | [2011/17] | Type: | B1 Patent specification | No.: | EP2223922 | Date: | 02.03.2016 | Language: | EN | [2016/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.03.2011 | Classification | IPC: | C07D473/38, C07D473/34, C07D473/00, C07D473/24, C07D473/16, C07D473/40, C07D473/30, C07D403/12, C07D487/04, A61K31/517, A61K31/52, A61P7/00, A61P29/00, A61P19/10 | [2011/17] | CPC: |
C07D473/00 (EP,US);
A61K31/52 (KR);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D403/12 (EP,US);
C07D473/16 (EP,US);
C07D473/24 (EP,US);
C07D473/30 (EP,US);
C07D473/34 (EP,US);
|
Former IPC [2010/35] | C07D473/00, C07D473/16, C07D473/24, C07D473/30, C07D473/34, C07D473/38, C07D473/40, A61K31/517, A61K31/52, A61P19/10, A61P35/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2016/09] |
Former [2010/35] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Extension states | AL | 20.05.2010 | LT | 20.05.2010 | LV | 20.05.2010 | MK | 20.05.2010 | RO | 20.05.2010 | SI | 20.05.2010 | Title | German: | Hemmer der menschlichen Phosphatidyl-inositol-3-kinase delta | [2010/35] | English: | Inhibitors of human phosphatidyl-inositol 3-kinase delta | [2010/35] | French: | Inhibiteurs delta de phosphatidyl-inositol 3-kinase humaine | [2010/35] | Examination procedure | 20.05.2010 | Examination requested [2010/35] | 13.10.2011 | Amendment by applicant (claims and/or description) | 25.03.2015 | Communication of intention to grant the patent | 04.08.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 19.08.2015 | Communication of intention to grant the patent | 15.12.2015 | Fee for grant paid | 15.12.2015 | Fee for publishing/printing paid | 15.12.2015 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP01928855.4 / EP1278748 | EP08006457.9 / EP1939203 | Divisional application(s) | EP15200992.4 / EP3029041 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010928855) is 13.07.2004 | Opposition(s) | 05.12.2016 | No opposition filed within time limit [2017/06] | Fees paid | Renewal fee | 20.05.2010 | Renewal fee patent year 03 | 20.05.2010 | Renewal fee patent year 04 | 20.05.2010 | Renewal fee patent year 05 | 20.05.2010 | Renewal fee patent year 06 | 20.05.2010 | Renewal fee patent year 07 | 20.05.2010 | Renewal fee patent year 08 | 20.05.2010 | Renewal fee patent year 09 | 20.05.2010 | Renewal fee patent year 10 | 12.04.2011 | Renewal fee patent year 11 | 28.03.2012 | Renewal fee patent year 12 | 29.04.2013 | Renewal fee patent year 13 | 28.04.2014 | Renewal fee patent year 14 | 27.04.2015 | Renewal fee patent year 15 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US3322756 (HEINRICH RUSCHIG, et al) [A] 1,11-13,23,24* columns 7, 8, table; column 3, lines 43-45 *; | [A]US3984555 (AMSCHLER HERMANN, et al) [A] 1,11-13,23,24 * claim 1; table VI *; | [A]US4183931 (RATHMAN TERRY L [US], et al) [A] 1,11-13,23,24 * example 2; claim 4 *; | [A]WO9417090 (GLAXO GROUP LTD [GB], et al) [A] 1,11-13,23,24 * page 1, line 3 - line 29; claims 1,14-16 *; | [A]WO9604923 (PRO NEURON INC [US]) [A] 1,11-13,23,24 * claims 1-4,7,8 *; | [A]WO9741097 (REDDY RESEARCH FOUNDATION [IN], et al) [A] 1,11-13,23,24 * examples 12-15,22,23,28,39-43; claims 1,17 *; | [A]WO9833802 (UNIV NEWCASTLE VENTURES LTD [GB], et al) [A] 1,11-13,23,24 * claims 1,20,22 *; | [A]WO9908501 (REDDY RESEARCH FOUNDATION [IN], et al) [A] 1,11-13,23,24 * examples 1-26,49-62; claims 1,25,26 *; | [A]WO9934804 (UNIV VIRGINIA [US]) [A] 1,11-13,23,24 * claims 3,4 * |